Among them, the L523 and N584 mutations in CML were recurrently found in C-terminal–proximal regions, indicating the functional importance of the C-terminal region of KLC2. The gene discussed is KLC2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.